REGULATED INFORMATION – Disclosure pursuant to article 15 of the Law of May 2, 2007 (the Transparency Law)
REGULATED INFORMATION – Disclosure pursuant to article 15 of the Law of May 2, 2007 (the Transparency Law)

REGULATED INFORMATION – Disclosure pursuant to article 15 of the Law of May 2, 2007 (the Transparency Law)

REGULATED INFORMATION

Disclosure pursuant to article 15 of the Law of May 2, 2007 (the Transparency Law)

Leuven, Belgium – March 23, 2021 – 18h00, Crescent NV, Gaston Geenslaan 14, 3001 Heverlee (Euronext Brussels: OPTI) The company’s share capital was increased by EUR 1,014,566 on March 18, 2021 by subscription to 32,500,000 shares by LDA Capital. The issue price of 0.0312174 EUR was established within the 30-trading-day price period following the issue of the first put option to LDA Capital based on 90% of the average of the VWAPs in this Price Period and in accordance with the terms of the capital commitment agreement with LDA Capital.

Upon completion of this capital increase and the issuance of 32,500,000 new shares, Crescent’s total capital as of March 18, 2021 is EUR 11,096,613.52. The capital is represented by 1,646,439,345 fully paid ordinary shares (=the denominator) as of the same date. There are no preference shares. Each of these shares gives one voting right at the General Meeting and these shares therefore represent the denominator for the purposes of transparency regulations (i.e., notifications in the event of reaching, exceeding, or falling below the statutory or legal thresholds).

In addition to the statutory thresholds, Crescent’s articles of association, in application of Article 18, §1 of the Transparency Act, provide for an additional statutory threshold of 3%.

A further 28,000,000 warrants have been issued which, if exercised, entitle the holder to one share each. Holders of warrants only have a consultative vote at the General Meeting of Shareholders.

 

CONTACT

Edwin Bex

Gaston Geenslaan 14

B-3001 Leuven, Belgium

TEL: +32 (0) 16 31 74 11

E-mail: investor@option.com

www.opticrescent.com

 

 

 

Related Posts

Investor relations

Ordinary General Meeting 2025

DATE SHAREHOLDERS’ MEETING: 30 May 2025 Convocation Ordinary General Meeting (including agenda) (NL) Convocation Ordinary General Meeting (including agenda) (UK)   Related documents Volmachtformulier Stemformulier ...
Annual Reports

Annual report 2024

Annual report 2024 (Dutch only) Annual report 2024 (ESEF version – Dutch only)
Financial news

REGULATED INFORMATION AND INSIDER INFORMATION – CRESCENT ANNUAL RESULTS 2024

Leuven, Belgium – 25 April– 7:30 CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Key points 2024 Results from continuing operations only (excluding ...
Scroll to Top